Back

Cell state-specific metabolic networks govern ferroptosis versus apoptosis in small cell lung cancer

Kim, J. W.; Bebber, C. M.; Dai, Y.; Bopp, S.; Edenhofer, A.; Li, A. M.; Rosner, T.; Berning, L.; Yang, M.; Leak, L. B.; Stroh, J.; Shrestha, B.; Abdallah, A.; Prymidis, D.; Olivos, H.; Baron, M.; Nguyen, T.; Shue, Y. T.; Nishiga, Y.; Drainas, A.; Chaikovsky, A.; Szylo, K.; Li, Y.; Kang, Y. P.; Manoj, P.; Quintanal Villalonga, A.; Rudin, C. M.; DeNicola, G. M.; Dixon, S. J.; Frezza, C.; Ye, J.; von Karstedt, S.; Sage, J.

2026-03-31 cancer biology
10.64898/2026.03.27.714827 bioRxiv
Show abstract

Cellular heterogeneity and plasticity are hallmarks of cancer that contribute to tumor growth and therapy resistance. Here we investigated metabolic heterogeneity in small cell lung cancer (SCLC), an aggressive neuroendocrine (NE) cancer type. Through integrated transcriptomic and metabolomic analyses, we identified a universal dependency on exogenous cysteine/cystine (Cys) across all NE/non-NE SCLC cell states. Notably, NE and non-NE cells with low levels of the ASCL1 transcription factor die from ferroptosis upon Cys depletion. In contrast, ASCL1-high cells die from apoptosis but are ferroptosis resistant. This resistance to ferroptosis is driven by the direct upregulation of the gene coding for the GCH1 enzyme by ASCL1, which results in higher levels of the BH4/BH2 antioxidants. Accordingly, combining cysteine depletion with BH4/BH2 synthesis inhibition effectively reduces tumor growth in patient-derived xenografts. This work elucidates distinct metabolic states in SCLC and suggests new approaches to induce cell death in this lethal form of cancer.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 12%
15.0%
Similar papers in this journal
2
eLife
● 5828 papers in training set
Top 20%
6.2%
Similar papers in this journal
3
Cancer Research
● 130 papers in training set
Top 0.6%
5.5%
Similar papers in this journal
4
Redox Biology
○ 70 papers in training set
Top 0.2%
5.1%
Similar papers in this journal
5
Science Advances
● 1243 papers in training set
Top 6%
4.8%
Similar papers in this journal
6
JCI Insight
● 277 papers in training set
Top 2%
3.2%
7
Communications Biology
○ 993 papers in training set
Top 6%
3.2%
8
Nature Metabolism
○ 69 papers in training set
Top 0.7%
3.1%
9
Cell Death & Differentiation
○ 48 papers in training set
Top 0.3%
3.1%
10
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 20%
2.6%
50% of probability mass above
11
Cell Reports
○ 1498 papers in training set
Top 15%
2.4%
12
Cancer Research Communications
● 51 papers in training set
Top 0.7%
2.1%
13
Journal of Clinical Investigation
● 179 papers in training set
Top 3%
1.9%
14
Molecular Oncology
○ 55 papers in training set
Top 0.7%
1.7%
15
Cancer Discovery
● 66 papers in training set
Top 1%
1.7%
16
eBioMedicine
○ 183 papers in training set
Top 3%
1.5%
17
Molecular Cell
○ 350 papers in training set
Top 4%
1.4%
18
Cell Metabolism
○ 57 papers in training set
Top 1%
1.1%
19
Nature Cancer
○ 39 papers in training set
Top 1%
1.1%
20
Cell Death & Disease
147 papers in training set
Top 3%
1.1%
21
Cancers
○ 213 papers in training set
Top 4%
1.1%
22
iScience
○ 1154 papers in training set
Top 33%
0.9%
23
Cancer Letters
○ 35 papers in training set
Top 1%
0.8%
24
EMBO Molecular Medicine
○ 95 papers in training set
Top 3%
0.8%
25
Life Science Alliance
● 285 papers in training set
Top 8%
0.8%
26
Journal of Cell Biology
● 392 papers in training set
Top 4%
0.8%
27
Signal Transduction and Targeted Therapy
○ 30 papers in training set
Top 0.6%
0.8%
28
Nature Cell Biology
○ 118 papers in training set
Top 3%
0.8%
29
Molecular Cancer Research
● 49 papers in training set
Top 1%
0.8%
30
Cell
○ 431 papers in training set
Top 10%
0.8%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.